Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

7680665480022 CH-66548 Konzentrat
Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/07/2025
Summary of Product Characteristics
Français
04/07/2025
Summary of Product Characteristics
Italien
04/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2325.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2018

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
66548
Drug name
Imfinzi, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FF03
Authorization status
Z
Dispensing category
A
First authorization
11/06/2018
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Package details

Description (FR)
IMFINZI conc perf 500 mg/10ml flac 10 ml
Description (DE)
IMFINZI Inf Konz 500 mg/10ml Durchstf 10 ml
Market launch
11/06/2018
Narcotic (BTM)
No

Other package sizes (1)

IMFINZI conc perf 120 mg/2.4ml flac 2.4 ml
1 DUR
GTIN: 7680665480015
View